Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study

By afschroeder • February 23, 2026

Armstrong AW, Gooderham MJ, Eyerich K, Reich K, Blauvelt A, Hong HC, Edwards RA, Bonfanti G, Clibborn C, Biswas P, Chan G, Feeney C, Güler E. Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study. J Am Acad Dermatol. 2026 Feb 20:S0190-9622(26)00284-7. doi: 10.1016/j.jaad.2026.02.066. Epub ahead of print. PMID: 41724439.

Tags: abrocitinib, atopic dermatitis, Dermatology, Dupilumab, head-to-head trial, high-threshold responses, Publications, Quality of Life, super-response

Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study

Bunick CG, Vleugels RA, Lebwohl M, Armstrong AW, Grada A, Yue EX, Saranadasa M, Wegrzyn L, D'Andrea E. Systemic Corticosteroid Exposure in Patients with Atopic[...]

AI and Digital Tools in Dermatology: Addressing Access and Misinformation

du Crest D, Madhumita M, Enbiale W, Ruiz Postigo JA, Malvehy J, Wongvibulsin S, Gupta S, Kittler H, Skayem C, Mahto A, Adamson AS, Lipoff[...]

Evaluating the Role of Dermatologic Continuity and Determinants of Psychiatric Engagement in Delusional Infestation: A Single-Institution Cross-Sectional Study

Yan MJ, Poppens MJ, Longstaff XR, Collier EK, Davis JC. Evaluating the Role of Dermatologic Continuity and Determinants of Psychiatric Engagement in Delusional Infestation: A[...]